Christina Brennan, MD, MBA, FACRP, is senior vice president of clinical research at The Feinstein Institutes for Medical Research at Northwell Health.
A Close Look at Clinical Trials in Oncology and Beyond: Looking Toward the Future
In this last episode, experts underscore the importance of incorporating the patient voice into clinical trial processes.
Read More
A Close Look at Clinical Trials in Oncology and Beyond: Efforts at Northwell
In this episode, experts discuss the growth and strategic development of Northwell's cancer clinical trial programs.
A Close Look at Clinical Trials in Oncology and Beyond: Leveraging AI
In this episode, experts discuss how artificial intelligence tools can enhance clinical trial recruitment, improve workforce efficiency, and more.
A Close Look at Clinical Trials in Oncology and Beyond: Recruitment and Inclusion
In this episode, experts highlight the increasing push to simplify cancer trial eligibility criteria and improve diversity in participant enrollment.
A Close Look at Clinical Trials in Oncology and Beyond: State of Affairs and Industry Progress
In this episode, experts discuss progress in cancer clinical trials and the challenges posed by the increasing complexity of therapies and protocols.
A Close Look at Clinical Trials in Oncology and Beyond: Boosting Accessibility
In this episode, experts emphasize the importance of providing flexible clinical trial options, such as satellite sites and remote follow-ups.
A Close Look at Clinical Trials in Oncology and Beyond: Barriers to Participation
In this episode, experts discuss the challenges of increasing awareness and participation in clinical trials.
A Close Look at Clinical Trials in Oncology and Beyond: Incorporating Into Standard Care
In this episode, experts discuss the importance of integrating clinical trials as a standard of care, particularly in the realm of oncology.
Durvalumab Plus Chemo May be Promising Neoadjuvant Option in UTUC
Dr Patel on the Potential for Adjuvant Immunotherapy in CSCC
Observation Is a Reasonable Alternative to Adjuvant PD-1 Blockade in Stage IIB/IIIC Melanoma
Dr Oluwole on CRS and Neurotoxicity Beyond 2 Weeks After Axi-Cel Infusion in R/R LBCL
MD Anderson Receives Nearly $23 Million in CPRIT Funding for Cancer Research, Faculty Recruitment
Identifying and Addressing the Overlooked Need of Patient Sexual Health
Radioligand Therapies and Emerging Targets Drive Innovation in Prostate Cancer Management